KemPharm, Inc.

1180 Celebration Boulevard, Suite 103

Celebration, FL 34747

(321) 939-3416

 

February 11, 2021

 

Via Edgar

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn:     Tim Buchmiller

 

Re:       KemPharm, Inc.

Registration Statement on Form S-3

File No. 333-252903

 

Acceleration Request

Requested Date:     Tuesday, February 16, 2021

Requested Time:     4:30 p.m. Eastern Time

 

Ladies and Gentlemen:

 

KemPharm, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on February 16, 2021 at 4:30 p.m. Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Brent Siler, Mark Ballantyne and Won Lee of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

 

Once the Registration Statement has been declared effective, please orally confirm that event with Brent Siler of Cooley LLP at (202) 728-7040 or in his absence, Mark Ballantyne of Cooley LLP at (703) 456-8084 or Won Lee of Cooley LLP at (720) 566-4238.

 

[Signature Page Follows]

 

 

Very truly yours,

 

KemPharm, Inc.

 

 

 

By: /s/ R. LaDuane Clifton                                  
Name:   R. LaDuane Clifton
Title:     Chief Financial Officer, Secretary and Treasurer

 

 

 

cc:	Travis C. Mickle, KemPharm, Inc.
	Brent Siler, Cooley LLP
	Mark Ballantyne, Cooley LLP
	Won Lee, Cooley LLP
	Charles Phillips, Ellenoff Grossman & Schole LLP